Outcomes of Surgical Versus Transcatheter Mitral Valve Repair or Replacement in Patients With Myocardial Infarction and Concomitant Mitral Regurgitation: A Retrospective Analysis of Real-World Data
Year: 2026
Type: article
Study design: Observational Study
Abstract: Myocardial infarction (MI) remains a major cause of morbidity and mortality in the United States, and up to half of patients with MI develop mitral regurgitation (MR).1 MR after MI reflects disruption of the left ventricle and mitral apparatus and is associated with increased risks of heart failure, rehospitalization, and mortality.2,3 Surgical mitral valve repair or replacement has traditionally been the mainstay of treatment for severe post-MI MR; however, operative risk is often high due to ventricular dysfunction, coronary disease burden, and comorbidities.
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,400
Funders: American Heart Association, Bristol-Myers Squibb, GlaxoSmithKline, Sanofi, Alnylam Pharmaceuticals, Cleveland Clinic, CSL Behring, Boston Scientific Corporation, Belvoir Media Group, Novo Nordisk, Assistance publique-Hôpitaux de Paris, National Institutes of Health, Science and Engineering Research Board, Duke Clinical Research Institute
OpenAlex ID: W7204822394